TrackBill does not support browsers with JavaScript disabled and some functionality may be missing, please follow these steps to enable it.

{{$root.universalMessage.text}}

Massachusetts S2695

An Act relative to pharmaceutical access, costs and transparency

Link to Summary Link to Summary

Link to Full Text Link to Full Text

On February 15, 2022 in the House:

Read; and referred to the committee on House Ways and Means

On February 10, 2022 in the Senate:

Text of S2651, printed as amended
Passed to be engrossed -see Roll Call #129 (Yeas 39 to Nays 1)

Senate Committee on Ways and Means

Type:

Primary Sponsor

MA - Senator Adam Hinds (D)

MA - Senator Cindy Friedman (D)

MA - Senator Diana DiZoglio (D)

MA - Senator Eric Lesser (D)

MA - Senator Jason Lewis (D)

MA - Senator Joanne Comerford (D)

MA - Senator Michael Moore (D)

MA - Senator Patrick O'Connor (R)

MA - Senator Walter Timilty (D)

MA - Representative Jack Lewis (D)

MA - Representative Michelle Ciccolo (D)

MA - Representative Peter Capano (D)

MA - Ways and Means (House)

Show previous .

Participants:

{{ teamMember.name ? teamMember.name : teamMember.email | escapeHtml | nl2br | trustHTML }} {{ teamMember.name ? teamMember.name : teamMember.email | escapeHtml | nl2br | trustHTML }}

{{ teamMember.name ? teamMember.name : teamMember.email | escapeHtml | nl2br | trustHTML }}

{{discussion.createdAt}} | delete | deleting | edit | cancel

Nothing posted by your team.

Select categories:

X

Clear all